Protia Inc. (KOSDAQ:303360)
5,250.00
+70.00 (1.35%)
At close: Sep 11, 2026
Protia Market Cap
Protia has a market cap or net worth of 67.62 billion as of September 11, 2026. Its market cap has decreased by -11.75% in one year.
Market Cap
67.62B
Enterprise Value
53.91B
Revenue
17.75B
Ranking
n/a
PE Ratio
12.35
Stock Price
5,250.00
ChartMarket Cap Chart
Since December 19, 2018, Protia's market cap has decreased from 78.41B to 67.62B, a decrease of -13.76%. That is a compound annual growth rate of -1.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 67.62B | -15.85% |
| Dec 30, 2025 | 80.35B | 127.74% |
| Dec 30, 2024 | 35.28B | -16.19% |
| Dec 28, 2023 | 42.10B | -45.57% |
| Dec 29, 2022 | 77.35B | 24.57% |
| Dec 30, 2021 | 62.09B | -38.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 234.26B |
| 3billion | 136.84B |
| GC Medical Science | 74.29B |
| GENINUS | 71.58B |
| Cytogen | 70.65B |
| Inventera | 68.98B |
| HLB Panagene | 53.45B |
| Seoulin Bioscience | 36.62B |